Search - Archive ouverte HAL Access content directly

Filter your results

17 Results
Author: personID (integer) : 1065139

Core-binding factor acute myeloid leukemia in first relapse: a retrospective study from the French AML Intergroup

A. Hospital , T. Prebet , S. Bertoli , X. Thomas , E. Tavernier et al.
Blood, 2014, 124 (8), pp.1312 - 1319. ⟨10.1182/blood-2014-01-549212⟩
Journal articles hal-01688071v1

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights

J.E. Martin , S. Khalife-Hachem , T. Grinda , M. Kfoury , S. Garciaz et al.
Annals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩
Journal articles hal-03623367v1
Image document

STAT5-dependent regulation of CDC25A by miR-16 controls proliferation and differentiation in FLT3-ITD acute myeloid leukemia

Gabrielle Sueur , Alison Boutet , Mathilde Gotanègre , Véronique Mansat-de Mas , Arnaud Besson et al.
Scientific Reports, 2020, 10 (1), pp.1906. ⟨10.1038/s41598-020-58651-x⟩
Journal articles inserm-02484454v1

Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia

Q Heydt , C. Larrue , E Saland , S. Bertoli , J-E Sarry et al.
Oncogene, 2018, 37 (6), pp.787-797. ⟨10.1038/onc.2017.376⟩
Journal articles hal-02329424v1
Image document

Outcome of AML patients with IDH2 mutations in real world before the era of IDH2 inhibitors

Laetitia Largeaud , Emilie Bérard , Sarah Bertoli , Stéphanie Dufrechou , Naïs Prade et al.
Leukemia Research, 2019, 81, pp.82 - 87. ⟨10.1016/j.leukres.2019.04.010⟩
Journal articles hal-03480701v1

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

Laetitia Largeaud , Pascale Cornillet-Lefebvre , Jean-François Hamel , Pierre-Yves Dumas , Naïs Prade et al.
Leukemia, 2021, 35 (5), pp.1291-1300. ⟨10.1038/s41375-020-01031-1⟩
Journal articles hal-03441014v1

Prognostic impact of day 15 blast clearance in risk-adapted remission induction chemotherapy for younger patients with acute myeloid leukemia: long term results of the multicenter prospective LAM-2001 trial by the GOELAMS study group.

Sarah Bertoli , Pierre Bories , Marie C Béné , Sylvie Daliphard , Bruno Lioure et al.
Haematologica, 2013, epub ahead of print. ⟨10.3324/haematol.2013.091819⟩
Journal articles hal-00854975v1

MAIT cells numbers and frequencies in patients with acute myeloid leukemia at diagnosis: association with cytogenetic profile and gene mutations

Thibault Comont , Marie-Laure Nicolau-Travers , Sarah Bertoli , Christian Recher , Francois Vergez et al.
Cancer Immunology, Immunotherapy, 2022, 71, pp.875-887. ⟨10.1007/s00262-021-03037-9⟩
Journal articles hal-03597702v1

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study

Laetitia Largeaud , Pascale Cornillet-Lefebvre , Jean-François Hamel , Pierre-Yves Dumas , Naïs Prade et al.
Leukemia, 2021, 35 (5), pp.1291-1300. ⟨10.1038/s41375-020-01031-1⟩
Journal articles hal-03623649v1
Image document

Inhibition of ubiquitin-specific protease 7 sensitizes acute myeloid leukemia to chemotherapy

Maëlle Cartel , Pierre-Luc Mouchel , Mathilde Gotanègre , Laure David , Sarah Bertoli et al.
Leukemia, 2021, 35, pp.417-432. ⟨10.1038/s41375-020-0878-x⟩
Journal articles hal-02908529v1
Image document

Autophagy regulates fatty acid availability for oxidative phosphorylation through mitochondria-endoplasmic reticulum contact sites

Claudie Bosc , Nicolas Broin , Marjorie Fanjul , Estelle Saland , Thomas Farge et al.
Nature Communications, 2020, 11 (1), pp.4056. ⟨10.1038/s41467-020-17882-2⟩
Journal articles inserm-02962997v1
Image document

Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients

Eloïse Berger , Cyrille Delpierre , Fabien Despas , Sarah Bertoli , Emilie Bérard et al.
BMC Cancer, 2019, 19 (1), pp.883. ⟨10.1186/s12885-019-6093-3⟩
Journal articles inserm-02326744v1
Image document

Dexamethasone in hyperleukocytic acute myeloid leukemia

Sarah Bertoli , Muriel Picard , Emilie Berard , Emmanuel Griessinger , Clément Larrue et al.
Haematologica, 2018, 103 (6), pp.988-998. ⟨10.3324/haematol.2017.184267⟩
Journal articles inserm-02465191v1
Image document

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights

J.E. Martin , S. Khalife-Hachem , T. Grinda , M. Kfoury , S. Garciaz et al.
Annals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩
Journal articles hal-03376715v1

Characteristics and Clinical Outcomes of SARS-CoV-2 Infection in Adult Patients with Acute Leukemia in France.

Pierre-Yves Dumas , Sarah Bertoli , Caroline Bonmati , Martin Carre , Juliette Lambert et al.
Leukemia Research, 2022, 120, pp.106901. ⟨10.1016/j.leukres.2022.106901⟩
Journal articles hal-03740506v1
Image document

Prise en charge des syndromes myélodysplasiques en 2019 : mise au point

T. Comont , K. Delavigne , P. Cougoul , S. Bertoli , E. Delabesse et al.
La Revue de Médecine Interne, 2019, 40, pp.581 - 589. ⟨10.1016/j.revmed.2019.04.001⟩
Journal articles hal-03488143v1
Image document

CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia

Sarah Bertoli , Helena Boutzen , Laure David , Clément Larrue , François Vergez et al.
Oncotarget, 2015, 6 (35), ⟨10.18632/oncotarget.5706⟩
Journal articles hal-01594827v1